Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Top U.S. proton pump inhibitors market share based on prescriptions 2013

This statistic displays the market share of the top ten proton pump inhibitors based on total U.S. prescriptions in 2013. In that year, Nexium was among the leading proton pump inhibitors with a total market share of 15.4 percent of prescriptions in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.

Top proton pump inhibitors based on U.S. prescriptions market share in 2013

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until December 20th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2014

Region

United States

Survey time period

2013

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.